glp-1 cardiovascular outcomes 2025 news ISPOR 2025: Exploring reasons for discontinuation GLP-1 Trends

As an investigational peptide not yet FDA-approved, retatrutide is available through research chemical suppliers and certain compounding pharmacies

This product is supplied for laboratory, analytical and scientific research conducted by qualified researchers and institutions

By tailoring each dose adjustment to the patient's specific progress and side effects, the guiding principle is to find the lowest effective dose that comfortably sustains long-term results, rather than rushing to the maximum dose in the shortest time possible

In contrast, synthetic polymer scaffolds, such as polycaprolactone, have a moderate porosity and high modulus, impacting their mechanical properties and biological performance